Kenvue Inc. (NYSE:KVUE) Shares Bought by Voya Investment Management LLC

Voya Investment Management LLC raised its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 22.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,244,684 shares of the company's stock after purchasing an additional 950,315 shares during the period. Voya Investment Management LLC owned 0.27% of Kenvue worth $111,974,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Norges Bank purchased a new position in shares of Kenvue in the 4th quarter worth $521,348,000. Franklin Resources Inc. raised its holdings in shares of Kenvue by 61.5% in the 4th quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company's stock worth $912,059,000 after purchasing an additional 16,269,721 shares during the period. Massachusetts Financial Services Co. MA grew its holdings in shares of Kenvue by 12.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company's stock worth $2,085,070,000 after purchasing an additional 10,682,003 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in Kenvue by 3.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company's stock valued at $5,249,665,000 after buying an additional 8,211,748 shares during the period. Finally, Boston Partners lifted its position in Kenvue by 36.9% during the fourth quarter. Boston Partners now owns 23,595,963 shares of the company's stock valued at $503,145,000 after buying an additional 6,366,097 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

KVUE has been the topic of several recent research reports. UBS Group reduced their target price on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Evercore ISI began coverage on Kenvue in a report on Monday, March 24th. They set an "in-line" rating and a $25.00 target price on the stock. Barclays decreased their price target on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Monday, April 14th. Redburn Atlantic assumed coverage on shares of Kenvue in a research note on Thursday, April 10th. They set a "neutral" rating and a $23.50 price objective on the stock. Finally, Citigroup upped their target price on shares of Kenvue from $21.00 to $22.00 and gave the company a "neutral" rating in a research note on Monday, April 14th. Eight equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $24.42.

Kenvue Stock Performance

NYSE KVUE traded up $0.11 on Monday, hitting $23.12. The stock had a trading volume of 12,011,898 shares, compared to its average volume of 17,099,284. The company's 50-day moving average is $23.03 and its two-hundred day moving average is $22.45. Kenvue Inc. has a one year low of $17.67 and a one year high of $24.46. The stock has a market cap of $44.36 billion, a price-to-earnings ratio of 43.62, a P/E/G ratio of 2.62 and a beta of 1.02. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, meeting analysts' consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. On average, analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.55%. The ex-dividend date is Wednesday, May 14th. Kenvue's dividend payout ratio (DPR) is presently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.